Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models
- 11 September 2002
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (10) , 825-829
- https://doi.org/10.1038/sj.cgt.7700503
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor modelThe Annals of Thoracic Surgery, 2000
- Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral AntigenicityJapanese Journal of Cancer Research, 2000
- Transduction Efficiency of Adenoviral Vectors into Human Glioma Cells Increased by Association with Cationic Liposomes.Neurologia medico-chirurgica, 2000
- Intraarterial Delivery of Adenovirus Vectors and Liposome-DNA Complexes to Experimental Brain NeoplasmsHuman Gene Therapy, 1999
- Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivoGene Therapy, 1998
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997
- Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cellsAtherosclerosis, 1996
- Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of HealthHuman Gene Therapy, 1993